iHub Stent-Graft for Iliac Artery Aneurysms: Safety, Performance, and Effectiveness Study
A legfontosabb adatok
- Ki végzi
- Archo Medical S.A
- Hol
- Florianópolis és São Paulo (Brazília)Mind a 2 helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 10 fő, tervezett
- Kezdés
- 2026. máj. 26.
- Várható befejezés
- 2028. dec.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Endovascular Iliac Branch Stent-Graft Implantation
- A regiszteradat frissítve
- 2026. augusztus 12.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with an aneurysm (a bulge) of the iliac artery in the pelvis who need repair through the blood vessels. They must already have an aorto-bi-iliac stent-graft in place.
- Életkor
- 18 years or older
- Nem
- All sexes
- A betegség stádiuma
- Iliac artery aneurysm. At least one of: common iliac aneurysm ≥ 25 mm wide; growth of 5 mm or more in the last six months; saccular aneurysm greater than 20 mm; abdominal aortic aneurysm extending less than 20 mm into the common iliac arteries. ASA physical status I to III, or ASA IV with life expectancy over one year.
- Korábbi kezelés
- Must have a previously implanted aorto-bi-iliac stent-graft with branch diameter between 14 and 16 mm.
A részvétel fő kizáró okai
- Pregnant or breastfeeding women, or women who could become pregnant
- Dissection, rupture, need for emergency surgery, or unstable angina
- Kidney problems (serum creatinine > 2.0 mg/dL (177 µmol/L)) or life expectancy under one year
- Class III obesity (BMI ≥ 40 kg/m²), connective tissue disease, or a tendency to form blood clots
- Allergy to device materials (ePTFE, FEP, Nitinol) or a body-wide infection
A regiszter feltételei, szó szerint
Mind a 21 feltétel megnézéseKevesebb
Ki vehet részt
- Meet at least one of the following criteria for iliac artery aneurysm:
- Common iliac artery aneurysm ≥ 25 mm in diameter
- Aneurysm growth of 5 mm or more within the last six months
- Maximum aneurysm diameter exceeds 1 to 1.5 times the normal arterial segment diameter, that is ≥ 25 mm maximum diameter
- Saccular aneurysm greater than 20 mm
- Abdominal aortic aneurysm with extension into the common iliac arteries of less than 20 mm; Have a previously implanted aorto-bi-iliac stent-graft with branch diameter between 14 and 16 mm; Have iliac/femoral access vessel morphology compatible with vascular access techniques, placement systems, devices, and/or accessories; Are classified as ASA physical status I to III. ASA IV patients may be included if their life expectancy is greater than one year; Are able and willing to comply with follow-up requirements during the 360-day post-implant period; -
Ki nem vehet részt
- Need for emergency surgery
- Congenital abnormalities where stent placement would obstruct a major artery. Such abnormalities must be assessed prior to treatment
- Contraindication to anticoagulation therapy
- Diffuse atherosclerotic disease in any common iliac artery reducing its diameter to < 4 mm
- Unstable angina
- Class III obesity (BMI ≥ 40 kg/m²) or other clinical conditions that severely limit radiographic visualization of the aorta
- Connective tissue disease (e.g., Marfan or Ehlers-Danlos syndrome)
- Presence of a systemic infection that could increase the risk of endovascular device infection
- Known sensitivity or allergy to device materials: expanded polytetrafluoroethylene (ePTFE), fluorinated ethylene propylene (FEP), or nickel-titanium (Nitinol)
- Acute or chronic renal insufficiency (serum creatinine > 2.0 mg/dL)
- A dissection, rupture, or complex vascular lesion due to trauma
- Contraindication to angiography
- Hypercoagulable state
- Life expectancy of less than one year
- -
Helyszínek itt: Brazília
- Instituto de Ensino e Pesquisa Dr. Irineu May Brodbeck - Hospital Baía Sul S/AFlorianópolis, BrazíliaContact: Cristiano T BortoluzziRésztvevőt keres
- Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo HcfmuspSão Paulo, BrazíliaContact: Grace C MulattiRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is to evaluate the safety, performance, and Preliminary effectiveness of the iHub endoprosthesis system in treating iliac artery aneurysms in adult patients requiring endovascular repair. The study population includes both male and female adults over 18 years of age who meet the inclusion criteria for endovascular treatment of iliac artery aneurysms.
A teljes eredeti leírásKevesebb
The main questions it aims to answer are:
Is the iHub stent-graft system safe for use in patients with iliac artery aneurysms? Does the iHub system demonstrate adequate technical performance and sustained patency over a 12-month follow-up period? Participants will undergo a minimally invasive endovascular procedure to implant the iHub endoprosthesis system. The device is designed to preserve internal iliac artery flow while excluding the aneurysmal segment.
Participants will:
Undergo pre-screening evaluations including clinical examination, laboratory tests, and imaging (CT angiography and ultrasound).
Undergo endovascular implantation of the iHub device. Attend follow-up visits at 30, 90, 180, and 360 days post-implant to assess clinical outcomes and device performance.
A vizsgálat csoportja
- Endovascular Implant of iHub Iliac Stent-Graft for Treatment of Iliac Artery AneurysmsA vizsgált kezelés
Eligible participants with an iliac artery aneurysm, or aneurysms of the iliac arteries, who have iliac/femoral access compatible with the delivery systems, and a previously implanted or concurrently implanted bifurcated aortic stent-graft with branch diameters between 14 and 16 mm, will undergo endovascular surgery for aneurysm treatment using the iHub device
Kezelés: Endovascular Iliac Branch Stent-Graft Implantation
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- iHub no Tratamento de Aneurismas ilíacos: Avaliação da Segurança, Desempenho e Eficácia.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. augusztus 12.